E. Mor

683 total citations
30 papers, 517 citations indexed

About

E. Mor is a scholar working on Surgery, Hepatology and Transplantation. According to data from OpenAlex, E. Mor has authored 30 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 12 papers in Hepatology and 9 papers in Transplantation. Recurrent topics in E. Mor's work include Organ Transplantation Techniques and Outcomes (12 papers), Liver Disease and Transplantation (9 papers) and Renal Transplantation Outcomes and Treatments (8 papers). E. Mor is often cited by papers focused on Organ Transplantation Techniques and Outcomes (12 papers), Liver Disease and Transplantation (9 papers) and Renal Transplantation Outcomes and Treatments (8 papers). E. Mor collaborates with scholars based in Israel, United States and United Kingdom. E. Mor's co-authors include Sukru Emre, Ran Tur‐Kaspa, Ziv Ben‐Ari, John F. Gibbs, Thomas A. Gonwa, Robert M. Goldstein, Linda W. Jennings, Bo S. Husberg, Michael J. Holman and Harvey Solomon and has published in prestigious journals such as Hepatology, American Journal of Transplantation and Journal of Internal Medicine.

In The Last Decade

E. Mor

27 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Mor Israel 14 309 252 189 92 45 30 517
Nelson Elias Mendes Gibelli Brazil 15 422 1.4× 360 1.4× 111 0.6× 61 0.7× 75 1.7× 34 546
Caroline Jézequel France 14 221 0.7× 275 1.1× 199 1.1× 93 1.0× 25 0.6× 32 532
Andreas G. Tzakis United States 10 372 1.2× 204 0.8× 126 0.7× 245 2.7× 19 0.4× 12 577
Panagiotis Fikatas Germany 12 402 1.3× 243 1.0× 153 0.8× 63 0.7× 128 2.8× 31 600
Thomas Shaw‐Stiffel United States 11 255 0.8× 383 1.5× 278 1.5× 17 0.2× 54 1.2× 21 633
Mical S. Campbell United States 17 375 1.2× 678 2.7× 529 2.8× 142 1.5× 39 0.9× 27 896
Göran Klintmalm United States 11 461 1.5× 627 2.5× 550 2.9× 178 1.9× 91 2.0× 21 966
Matthew Bowles United Kingdom 14 555 1.8× 520 2.1× 205 1.1× 119 1.3× 85 1.9× 33 827
Tarkan Ünek Türkiye 15 379 1.2× 212 0.8× 140 0.7× 40 0.4× 134 3.0× 86 656
Deok Gie Kim South Korea 10 147 0.5× 119 0.5× 92 0.5× 66 0.7× 75 1.7× 59 332

Countries citing papers authored by E. Mor

Since Specialization
Citations

This map shows the geographic impact of E. Mor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Mor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Mor more than expected).

Fields of papers citing papers by E. Mor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Mor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Mor. The network helps show where E. Mor may publish in the future.

Co-authorship network of co-authors of E. Mor

This figure shows the co-authorship network connecting the top 25 collaborators of E. Mor. A scholar is included among the top collaborators of E. Mor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Mor. E. Mor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mor, E., et al.. (2024). Gameful Experience Scale: Reliability and Validity in Nursing Students. Games for Health Journal. 13(6). 443–451. 1 indexed citations
2.
Mor, E., et al.. (2023). Psychosocial Intervention Programs in Natural Disaster Affected Individuals: A Systematic Review. DergiPark (Istanbul University). 0(3). 41–51.
3.
Rahamimov, Ruth, Elad Goldberg, Leonard Leibovici, et al.. (2012). Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: retrospective observational study. European Journal of Clinical Microbiology & Infectious Diseases. 32(1). 127–131. 47 indexed citations
4.
Ben‐Ari, Ziv, E. Mor, & Ran Tur‐Kaspa. (2003). Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature. Journal of Internal Medicine. 253(5). 544–552. 23 indexed citations
5.
Schmilovitz‐Weiss, Hemda, E. Mor, Jaqueline Sulkes, et al.. (2003). De novo tumors after liver transplantation: a single-center experience. Transplantation Proceedings. 35(2). 665–666. 14 indexed citations
6.
Schmilovitz‐Weiss, Hemda, E. Mor, E Shaharabani, et al.. (2003). Association of post-liver transplantation diabetes mellitus with hepatitis C virus infection. Transplantation Proceedings. 35(2). 667–668. 10 indexed citations
7.
Wasserberg, Nir, Shashikumar K. Salgar, Degang Yang, et al.. (2003). Tacrolimus does not upregulate mucin gene expression after small bowel transplantation in rats. Transplantation Proceedings. 35(2). 670–671. 1 indexed citations
8.
Ben‐Ari, Ziv, et al.. (2001). Passive immunization with OMRI-hep-B for prevention of hepatitis B virus reinfection after liver transplantation. Transplantation Proceedings. 33(6). 2895–2896. 5 indexed citations
9.
Emre, Sukru, A. Sébastian, Lawrence Chodoff, et al.. (2000). Selective decontamination of the digestive tract helps prevent bacterial infections in the early postoperative period after liver transplant.. PubMed. 66(5-6). 310–3. 22 indexed citations
10.
Shaharabani, E, E. Mor, D Shmueli, et al.. (1997). A 5-year experience in liver transplantation at Rabin Medical Center, Israel. Transplantation Proceedings. 29(6). 2642–2643. 1 indexed citations
11.
Wolf, Douglas C., Patrizia Boccagni, E. Mor, et al.. (1997). Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients. Liver Transplantation and Surgery. 3(6). 598–603. 27 indexed citations
12.
Shmueli, D, et al.. (1997). Loss of serum HBsAg after interferon-A therapy in liver transplant patients with recurrent hepatitis-B infection. Liver Transplantation and Surgery. 3(4). 394–397. 2 indexed citations
13.
Mor, E., D Shmueli, N Bar-Nathan, et al.. (1997). Utilization of liver allografts from donors older than 60 in Israel: Benefits and risks. Transplantation Proceedings. 29(7). 3079–3080. 4 indexed citations
14.
Skerrett, Donna, et al.. (1996). Plasmapheresis in primary dysfunction of hepatic transplants. Journal of Clinical Apheresis. 11(1). 10–13. 17 indexed citations
15.
Bronster, David J., Sukru Emre, E. Mor, et al.. (1994). Neurologic complications of orthotopic liver transplantation.. PubMed. 61(1). 63–9. 41 indexed citations
16.
Emre, Sukru, E. Mor, M. E. Schwartz, et al.. (1993). Liver transplantation in patients beyond age 60.. PubMed. 25(1 Pt 2). 1075–6. 31 indexed citations
17.
Mor, E., Linda W. Jennings, Thomas A. Gonwa, et al.. (1993). The impact of operative bleeding on outcome in transplantation of the liver.. PubMed. 176(3). 219–27. 122 indexed citations
18.
Mor, E.. (1993). FK 506 hepatotoxicity in liver allograft recipients. Hepatology. 18(4). A75–A75. 1 indexed citations
19.
Schwartz, Myron, et al.. (1993). Acute portal vein thrombosis: a cause of rapid deterioration of liver function, treatable by thrombectomy and transplantation.. PubMed. 25(2). 1972–1972. 2 indexed citations
20.
Mor, E., et al.. (1992). Delayed operation for acute pancreatitis.. PubMed. 28(11). 779–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026